The cardiovascular response to digoxin in conscious dogs with left atrial obstruction

Paul M. Heerdt, Robert William Caldwell

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

In addition to positive inotropic and atrioventricular conduction-blocking properties, digoxin is capable of producing systemic and pulmonary vasoconstriction. However, whether chronic digoxin treatment exacerbates the pulmonary hypertension that results from left atrial (LA) outflow obstruction has not been specifically examined. This study assessed the vascular and inotropic responses to 5 days of digoxin treatment in six conscious dogs before and after filling a permanently implanted LA balloon. Dogs were also instrumented to measure left ventricular (LV) pressure, LV dP/dt, mean systemic arterial (MAP), right atrial (RAP), pulmonary arterial, and pulmonary capillary wedge pressures, as well as cardiac output (CO). Under normal conditions with the balloon empty, digoxin treatment (40 μg/kg loading dose and 12 μg/kg/d for 5 days) reduced CO (−17%) and increased systemic (SVR) and pulmonary (PVR) vascular resistances 27% and 37%, respectively; heart rate (HR) and LV dP/dt were not changed. Filling the balloon with enough saline to double PVR also increased SVR (52%), HR (42%), and RAP (92%), and reduced CO (−24%). During LA outflow obstruction, 5 days of digoxin reduced HR (−17%). SVR (−29%), and RAP (−23%), but did not alter PVR, CO, or LV dP/dt. This study demonstrates that although systemic and pulmonary vasoconstriction result from chronic digoxin treatment under normal conditions, the drug produces systemic vasodilation and no change in PVR during LA outflow obstruction.

Original languageEnglish (US)
Pages (from-to)687-694
Number of pages8
JournalJournal of Cardiothoracic Anesthesia
Volume4
Issue number6
DOIs
StatePublished - Jan 1 1990
Externally publishedYes

Fingerprint

Digoxin
Dogs
Cardiac Output
Heart Rate
Vasoconstriction
Lung
Pulmonary Wedge Pressure
Ventricular Pressure
Pulmonary Hypertension
Vasodilation
Vascular Resistance
Blood Vessels
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Anesthesiology and Pain Medicine

Cite this

The cardiovascular response to digoxin in conscious dogs with left atrial obstruction. / Heerdt, Paul M.; Caldwell, Robert William.

In: Journal of Cardiothoracic Anesthesia, Vol. 4, No. 6, 01.01.1990, p. 687-694.

Research output: Contribution to journalArticle

@article{773649921b364a7a8e48b0b7ca6a460b,
title = "The cardiovascular response to digoxin in conscious dogs with left atrial obstruction",
abstract = "In addition to positive inotropic and atrioventricular conduction-blocking properties, digoxin is capable of producing systemic and pulmonary vasoconstriction. However, whether chronic digoxin treatment exacerbates the pulmonary hypertension that results from left atrial (LA) outflow obstruction has not been specifically examined. This study assessed the vascular and inotropic responses to 5 days of digoxin treatment in six conscious dogs before and after filling a permanently implanted LA balloon. Dogs were also instrumented to measure left ventricular (LV) pressure, LV dP/dt, mean systemic arterial (MAP), right atrial (RAP), pulmonary arterial, and pulmonary capillary wedge pressures, as well as cardiac output (CO). Under normal conditions with the balloon empty, digoxin treatment (40 μg/kg loading dose and 12 μg/kg/d for 5 days) reduced CO (−17{\%}) and increased systemic (SVR) and pulmonary (PVR) vascular resistances 27{\%} and 37{\%}, respectively; heart rate (HR) and LV dP/dt were not changed. Filling the balloon with enough saline to double PVR also increased SVR (52{\%}), HR (42{\%}), and RAP (92{\%}), and reduced CO (−24{\%}). During LA outflow obstruction, 5 days of digoxin reduced HR (−17{\%}). SVR (−29{\%}), and RAP (−23{\%}), but did not alter PVR, CO, or LV dP/dt. This study demonstrates that although systemic and pulmonary vasoconstriction result from chronic digoxin treatment under normal conditions, the drug produces systemic vasodilation and no change in PVR during LA outflow obstruction.",
author = "Heerdt, {Paul M.} and Caldwell, {Robert William}",
year = "1990",
month = "1",
day = "1",
doi = "10.1016/S0888-6296(09)90005-9",
language = "English (US)",
volume = "4",
pages = "687--694",
journal = "Journal of Cardiothoracic and Vascular Anesthesia",
issn = "1053-0770",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - The cardiovascular response to digoxin in conscious dogs with left atrial obstruction

AU - Heerdt, Paul M.

AU - Caldwell, Robert William

PY - 1990/1/1

Y1 - 1990/1/1

N2 - In addition to positive inotropic and atrioventricular conduction-blocking properties, digoxin is capable of producing systemic and pulmonary vasoconstriction. However, whether chronic digoxin treatment exacerbates the pulmonary hypertension that results from left atrial (LA) outflow obstruction has not been specifically examined. This study assessed the vascular and inotropic responses to 5 days of digoxin treatment in six conscious dogs before and after filling a permanently implanted LA balloon. Dogs were also instrumented to measure left ventricular (LV) pressure, LV dP/dt, mean systemic arterial (MAP), right atrial (RAP), pulmonary arterial, and pulmonary capillary wedge pressures, as well as cardiac output (CO). Under normal conditions with the balloon empty, digoxin treatment (40 μg/kg loading dose and 12 μg/kg/d for 5 days) reduced CO (−17%) and increased systemic (SVR) and pulmonary (PVR) vascular resistances 27% and 37%, respectively; heart rate (HR) and LV dP/dt were not changed. Filling the balloon with enough saline to double PVR also increased SVR (52%), HR (42%), and RAP (92%), and reduced CO (−24%). During LA outflow obstruction, 5 days of digoxin reduced HR (−17%). SVR (−29%), and RAP (−23%), but did not alter PVR, CO, or LV dP/dt. This study demonstrates that although systemic and pulmonary vasoconstriction result from chronic digoxin treatment under normal conditions, the drug produces systemic vasodilation and no change in PVR during LA outflow obstruction.

AB - In addition to positive inotropic and atrioventricular conduction-blocking properties, digoxin is capable of producing systemic and pulmonary vasoconstriction. However, whether chronic digoxin treatment exacerbates the pulmonary hypertension that results from left atrial (LA) outflow obstruction has not been specifically examined. This study assessed the vascular and inotropic responses to 5 days of digoxin treatment in six conscious dogs before and after filling a permanently implanted LA balloon. Dogs were also instrumented to measure left ventricular (LV) pressure, LV dP/dt, mean systemic arterial (MAP), right atrial (RAP), pulmonary arterial, and pulmonary capillary wedge pressures, as well as cardiac output (CO). Under normal conditions with the balloon empty, digoxin treatment (40 μg/kg loading dose and 12 μg/kg/d for 5 days) reduced CO (−17%) and increased systemic (SVR) and pulmonary (PVR) vascular resistances 27% and 37%, respectively; heart rate (HR) and LV dP/dt were not changed. Filling the balloon with enough saline to double PVR also increased SVR (52%), HR (42%), and RAP (92%), and reduced CO (−24%). During LA outflow obstruction, 5 days of digoxin reduced HR (−17%). SVR (−29%), and RAP (−23%), but did not alter PVR, CO, or LV dP/dt. This study demonstrates that although systemic and pulmonary vasoconstriction result from chronic digoxin treatment under normal conditions, the drug produces systemic vasodilation and no change in PVR during LA outflow obstruction.

UR - http://www.scopus.com/inward/record.url?scp=0025604151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025604151&partnerID=8YFLogxK

U2 - 10.1016/S0888-6296(09)90005-9

DO - 10.1016/S0888-6296(09)90005-9

M3 - Article

VL - 4

SP - 687

EP - 694

JO - Journal of Cardiothoracic and Vascular Anesthesia

JF - Journal of Cardiothoracic and Vascular Anesthesia

SN - 1053-0770

IS - 6

ER -